Sarah C. Nabinger

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Nadia Harbeck, Priya Rastogi, Miguel Martín et al. · Annals of Oncology · 2021 · 378 citations · Full text

Medicine, Oncology, Pharmacology +16

Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)

Xian Zhang, Yantao He, Sijiu Liu et al. · Journal of Medicinal Chemistry · 2010 · 205 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway

Sisi Chen, Qiang Wang, Hao Yu et al. · Nature Communications · 2019 · 119 citations · Full text

Medicine, Genetics, Hematology +17

Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL

Raghuveer Singh Mali, Baskar Ramdas, Peilin Ma et al. · Cancer Cell · 2011 · 98 citations · Full text

Medicine, Molecular Biology, Oncology +14

Pathophysiological role of microRNA-29 in pancreatic cancer stroma

Jason J. Kwon, Sarah C. Nabinger, Zachary Vega et al. · Scientific Reports · 2015 · 70 citations · Full text

Medicine, Biomedical Sciences, Oncology +17